
Novartis narrowed its mid-term sales growth outlook to 5% annually through 2031 at its London investor day, as patent expirations weigh on the Swiss drugmaker.
Jennifer Smith, PhD, executive director, independent medical education of Wyeth, discusses the future role of CME in healthcare reform and gives advice on what makes a good CME professional.






